Pristimerin exhibits in vitro and in vivo anticancer activities through inhibition of nuclear factor- кB signaling pathway in colorectal cancer cells

Conclusion : Pristimerin antitumor activities were mainly mediated through inhibition of NF-кB signaling pathway in colon tumor cells. These findings further explain that pristimerin has the therapeutic potential for targeting colon cancer. Graphical abstract
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research